ATE297737T1 - Zusatz aus kräutern zur behandlung von kognitiven störungen aufgrund von östrogenverlust - Google Patents

Zusatz aus kräutern zur behandlung von kognitiven störungen aufgrund von östrogenverlust

Info

Publication number
ATE297737T1
ATE297737T1 AT00913309T AT00913309T ATE297737T1 AT E297737 T1 ATE297737 T1 AT E297737T1 AT 00913309 T AT00913309 T AT 00913309T AT 00913309 T AT00913309 T AT 00913309T AT E297737 T1 ATE297737 T1 AT E297737T1
Authority
AT
Austria
Prior art keywords
estrogen
loss
treatment
cognitive disorders
disorders due
Prior art date
Application number
AT00913309T
Other languages
English (en)
Inventor
Tricia Grose
Original Assignee
Tricia Grose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tricia Grose filed Critical Tricia Grose
Application granted granted Critical
Publication of ATE297737T1 publication Critical patent/ATE297737T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00913309T 2000-01-28 2000-01-28 Zusatz aus kräutern zur behandlung von kognitiven störungen aufgrund von östrogenverlust ATE297737T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/002474 WO2001054697A1 (en) 2000-01-28 2000-01-28 Herbal supplement for cognitive related impairment due to estrogen loss

Publications (1)

Publication Number Publication Date
ATE297737T1 true ATE297737T1 (de) 2005-07-15

Family

ID=21741020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00913309T ATE297737T1 (de) 2000-01-28 2000-01-28 Zusatz aus kräutern zur behandlung von kognitiven störungen aufgrund von östrogenverlust

Country Status (10)

Country Link
EP (1) EP1261345B1 (de)
AT (1) ATE297737T1 (de)
AU (2) AU3477900A (de)
CA (1) CA2398747C (de)
DE (1) DE60020888T2 (de)
DK (1) DK1261345T3 (de)
ES (1) ES2243241T3 (de)
NZ (1) NZ520474A (de)
PT (1) PT1261345E (de)
WO (1) WO2001054697A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426097B2 (en) 2000-01-28 2002-07-30 Herbaceuticals Inc. Herbal supplement for cognitive related impairment due to estrogen loss
US20030162770A1 (en) * 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease

Also Published As

Publication number Publication date
DE60020888T2 (de) 2006-05-11
CA2398747C (en) 2011-07-19
ES2243241T3 (es) 2005-12-01
NZ520474A (en) 2004-09-24
EP1261345B1 (de) 2005-06-15
AU2000234779B2 (en) 2005-11-10
AU3477900A (en) 2001-08-07
DK1261345T3 (da) 2005-09-12
EP1261345A1 (de) 2002-12-04
WO2001054697A1 (en) 2001-08-02
CA2398747A1 (en) 2001-08-02
PT1261345E (pt) 2005-10-31
DE60020888D1 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
DE60206474D1 (de) Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts
FR2788438B1 (fr) Composition pour le traitement de l'obesite et procede de traitement esthetique
ATE412417T1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
ATE382360T1 (de) Wasser/ethanol pflanzenextrakte aus centipeda cunninghamii
DE60123415D1 (de) Fraktionierung und behandlung von ölsaatmehl
ATE536858T1 (de) Zubereitung auf basis natürlicher extrakte zur vorbeugung und behandlung von hautfalten
FR2808191B1 (fr) Extrait de vegetal de l'espece olea europaea comme inhibiteur de no-synthase et utilisations
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
DE60020888D1 (de) Zusatz aus kräutern zur behandlung von kognitiven störungen aufgrund von östrogenverlust
ATE479333T1 (de) Kräuterpulverextrakte und verfahren zu ihrer herstellung und anwendung
DE60030786D1 (de) Murraya koenigii-extrakte zur behandlung von asthma
DE60107441D1 (de) Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
DE50113351D1 (de) Zubereitungen enthaltend einen extrakt der pflanze pistia stratiotes
ATE303814T1 (de) Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos
ATE532521T1 (de) Verwendung eines östrogens bei der herstellung einer östrogenhaltigen zusammensetzung zur behandlung von atrophischer vaginitis
ATE271876T1 (de) Verwendung einer synergistischen zusammensetzung zur herstellung eines medikaments zur behandlung von lebererkrankungen
TW200806307A (en) Medical compositions for inhibiting brain tumor
DE50213671D1 (de) Wirkstoffmischung enthaltend ein pflanzenextrakt von convolvulaceae zur behandlung von haarproblemen, hautstörungen, hautkrankheiten
BG103222U (en) Prophylactic form - medicinal herb preparation of the white thorn plant
Rastogi et al. Constituents of Mallotus nepalensis Muell. Arg.: a Mild CNS Depressant
LSkkkk French National Infitut. 2ɔ
EA200201229A1 (ru) Экстракт nerium oleander, композиции, содержащие фиксированные комбинации экстракта nerium oleander l., и способ получения этого экстракта
UA74427C2 (uk) Склад для лікування хворих із захворюваннями, викликаними мембраноклітинними патологіями
TW200512001A (en) Extract from the leaves of Toona sinensis Roem., and the preparation process and uses thereof
TW200744620A (en) Medical compositions for inhibiting brain tumor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties